Video

Resilience Capacity Update May 2024: Cell & Gene Therapy

Source: Resilience US, Inc.

Resilience is excited to participate and provide an overview of Cell & Gene Therapy Capabilities at our prominent North America sites. Founded in 2020, Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. With a strong network of 11 sites located across North America supporting 5 modalities from development through commercial manufacturing, Resilience provides innovative solutions and services for established and emerging therapies. Hear from Eytan Abraham, Business Head of Cell Therapy, Gene Therapy & Nucleic Acids, and learn about how Resilience can support your development and manufacturing programs.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online